Neuronal VCP loss of function recapitulates FTLD-TDP pathology

Abubakar Wani,Jiang Zhu,Jason D. Ulrich,Abdallah Eteleeb,Andrew D. Sauerbeck,Sydney J. Reitz,Khalid Arhzaouy,Chiseko Ikenaga,Carla M. Yuede,Sara K. Pittman,Feng Wang,Shan Li,Bruno A. Benitez,Carlos Cruchaga,Terrance T. Kummer,Oscar Harari,Tsui-Fen Chou,Rolf Schröder,Christoph S. Clemen,Conrad C. Weihl

DOI: https://doi.org/10.1016/j.celrep.2021.109399

IF: 8.8

2021-07-01

Cell Reports

Abstract:The pathogenic mechanism by which dominant mutations in <em>VCP</em> cause multisystem proteinopathy (MSP), a rare neurodegenerative disease that presents as fronto-temporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), remains unclear. To explore this, we inactivate <em>VCP</em> in murine postnatal forebrain neurons (VCP conditional knockout [cKO]). VCP cKO mice have cortical brain atrophy, neuronal loss, autophago-lysosomal dysfunction, and TDP-43 inclusions resembling FTLD-TDP pathology. Conditional expression of a single disease-associated mutation, VCP-R155C, in a VCP null background similarly recapitulates features of VCP inactivation and FTLD-TDP, suggesting that this MSP mutation is hypomorphic. Comparison of transcriptomic and proteomic datasets from genetically defined patients with FTLD-TDP reveal that progranulin deficiency and VCP insufficiency result in similar profiles. These data identify a loss of VCP-dependent functions as a mediator of FTLD-TDP and reveal an unexpected biochemical similarity with progranulin deficiency.

cell biology

What problem does this paper attempt to address?

This paper aims to explore the specific mechanisms of multisystem proteinopathy (MSP) caused by valosin - containing protein (VCP) gene mutations, especially how these mutations cause frontotemporal cortex neuron degeneration (FTLD - TDP). Specifically, the study conditionally knocked out the VCP gene in the hindbrain neurons of mice to observe its impact on neurodegenerative diseases and the similarity to the pathological features of human FTLD - TDP. In addition, the study also explored the expression of VCP mutants (such as VCP - R155C) in the context of VCP deletion to verify whether these mutations are hypomorphic, that is, partially lose their functions. Finally, by comparing the transcriptome and proteome data of the VCP - deficient mouse model with those of patients with progranulin (GRN) gene defects, the molecular similarities between VCP loss - of - function and GRN deficiency were revealed, thus providing a new perspective for understanding the pathogenesis of FTLD - TDP. ### Main findings: 1. **Pathological changes caused by VCP loss - of - function**: - Mice with conditional knockout of the VCP gene showed cortical brain atrophy, neuron loss, autophagy - lysosome dysfunction, and TDP - 43 inclusion body formation, and these pathological features were similar to those of FTLD - TDP patients. - Mice with conditional expression of the VCP - R155C mutation also showed similar pathological features, indicating that this mutation is hypofunctional. 2. **Functional characteristics of VCP mutations**: - The study showed that the expression of the VCP - R155C mutant in neurons led to a pathological phenotype similar to the complete inactivation of VCP, further supporting the view that this mutation is a hypofunctional mutation. 3. **Molecular similarities between VCP loss - of - function and GRN deficiency**: - Transcriptome and proteome analyses showed that the transcriptional and protein expression profiles of VCP loss - of - function were similar to those of the brain tissues of patients with GRN gene defects, suggesting that these two diseases may share some common pathological mechanisms. ### Significance: This study not only deepens the understanding of the mechanisms by which VCP mutations lead to FTLD - TDP, but also reveals the molecular link between VCP loss - of - function and GRN deficiency, providing a theoretical basis for the future development of treatment strategies for these diseases.

Neuronal VCP loss of function recapitulates FTLD-TDP pathology

VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

A pathogenic mutation in the ALS/FTD gene VCP induces mitochondrial hypermetabolism by modulating the permeability transition pore

Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels

4R tau drives endolysosomal and autophagy dysfunction in frontotemporal dementia

A TDP-43 acetylation-mimic mutation that disrupts RNA-binding drives FTLD-like neurodegeneration in a mouse model of sporadic TDP-43 proteinopathy

Fatty links between multisystem proteinopathy and small VCP-interacting protein

VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle

Aberrant neural activity in prefrontal pyramidal neurons lacking TDP-43 precedes neuron loss

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of ALS/FTD patients

Enhanced legumain activity links progranulin deficiency to TDP-43 pathology in frontotemporal lobar degeneration

A model of human neural networks reveals NPTX2 pathology in ALS and FTLD

Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB

iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy

Depletion of TDP-43 exacerbates tauopathy-dependent brain atrophy by sensitizing vulnerable neurons to caspase 3-mediated endoproteolysis of tau in a mouse model of Multiple Etiology Dementia

Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration